Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This isn't surprising given that this was the first company to bring a tubeless insulin delivery device to market back in 2006
Research indicates that oxidative stress impairs muscle recovery and function
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
Multiple preclinical studies have identified that BPC-157 increases vascular endothelial growth factor (VEGF) protein and gene expression, a critical pathway in tissue repair and regeneration
